SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000899140-20-000388
Filing Date
2020-08-31
Accepted
2020-08-31 15:10:08
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A (AMENDMENT NO. 2) i37091016a.htm SC 13D/A 35374
2 EXHIBIT 6 i37091016b.htm EX-99.1 341254
  Complete submission text file 0000899140-20-000388.txt   378443
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005 6502389600
Innoviva, Inc. (Filed by) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 (781) 810-0120
Entasis Therapeutics Holdings Inc. (Subject) CIK: 0001724344 (see all company filings)

IRS No.: 824592913 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90651 | Film No.: 201151265
SIC: 2834 Pharmaceutical Preparations